Concepedia

MD Scholl

MS

Statistics

Publications

8

Citations

261

H-Index

8

Active since

1996

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University Wexner Medical Center

MD Scholl is an author at The Ohio State University specializing in medicine, hematology, and transplant immunology.

Publications per year

1996–2004

8

Publications

8

Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation

EA Copelan, TP Bechtel, BR Avalos et al. · Bone Marrow Transplantation · 2001 · 69 citations

, , +13

Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma

EA Copelan, SL Penza, Brad Pohlman et al. · Bone Marrow Transplantation · 2000 · 57 citations

, , +7

Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease.

Edward A. Copelan, S K Ceselski, Susan A. Ezzone et al. · Journal of Clinical Oncology · 1997 · 53 citations

, , +16

Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation

EA Copelan, SL Penza, PJ Elder et al. · Bone Marrow Transplantation · 2000 · 29 citations

, , +17

The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy

EA Copelan, SL Penza, KS Theil et al. · Bone Marrow Transplantation · 2000 · 18 citations

, , +8

1–5 of 8